Dr. Kvols is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12902 Usf Magnolia Dr
Tampa, FL 33612Phone+1 813-903-3519Fax+1 813-745-7229
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1973 - 1975
Johns Hopkins UniversityResidency, Internal Medicine, 1970 - 1973
Baylor College of MedicineClass of 1970
Certifications & Licensure
FL State Medical License 2002 - 2015
Clinical Trials
- Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Start of enrollment: 1998 Jan 01
- Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer Start of enrollment: 2000 Jul 01
- Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors Start of enrollment: 2007 Aug 01
Publications & Presentations
PubMed
- 108 citationsSelective Hepatic Artery Embolization for Treatment of Patients With Metastatic Carcinoid and Pancreatic Endocrine TumorsJonathan R. Strosberg, Junsung Choi, Alan B. Cantor, Larry K. Kvols
Cancer Control. 2006-01-01 - 317 citationsHepatic resection for metastatic neuroendocrine carcinomasFlorencia G. Que, David M. Nagorney, Kenneth P. Batts, Laurie J. Linz, Larry K. Kvols
American Journal of Surgery. 1995-01-01 - 70 citationsIncidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumorsMichael C. Trendle, Charles G. Moertel, Larry K. Kvols
Cancer. 1997-02-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
